C12Q 2522/101
Single or double stranded nucleic acid binding proteins
C12Q2522/101 (Single or double stranded nucleic acid binding proteins) appears on 30 US grants and 45 published applications in this corpus.
Search patents in C12Q- Granted patents
- 30
- Published applications
- 45
- Assignees
- 28
- Inventors
- 90
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 3 |
| 2015 | 0 | 2 |
| 2016 | 2 | 1 |
| 2017 | 1 | 4 |
| 2018 | 2 | 5 |
| 2019 | 3 | 5 |
| 2020 | 4 | 7 |
| 2021 | 3 | 3 |
| 2022 | 2 | 1 |
| 2023 | 4 | 3 |
| 2024 | 2 | 3 |
| 2025 | 1 | 3 |
| 2026 | 3 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for genome assembly and haplotype phasing1 Sep 2026US 12,725,678 B2The Regents of the University of California
- RNA-directed DNA cleavage by the Cas9-crRNA complex23 Jun 2026US 12,662,668 B2Vilnius University
- Method for designing RNA binding protein utilizing PPR motif, and use thereof2 Jun 2026US 12,646,586 B2Kyushu University, National University Corporation
- Methods and compositions for enriching nucleic acids4 Mar 2025US 12,241,115 B2Asklepios Biopharmaceutical, Inc.
- Method of amplifying circular DNA3 Dec 2024US 12,157,915 B2Moderna Enzymatics Co., Ltd.
- Method for designing rna binding protein utilizing ppr motif, and use thereof14 May 2026US 2026/0134942 A9Kyushu University, National University Corporation
- Methods and compositions for enriching nucleic acids11 Sep 2025US 2025/0283148 A1Asklepios Biopharmaceutical, Inc.
- Method of Amplifying Circular DNA6 Feb 2025US 2025/0043341 A1Moderna Enzymatics Co., Ltd.
- Systems and methods for detection and quantification of double-stranded rna9 Jan 2025US 2025/0012785 A1Promega Corporation
- Polynucleotide amplification using crispr-cas systems19 Dec 2024US 2024/0417787 A1Illumina, Inc.
Most cited
By later US patents
- In vitro recombination method73US 7,723,077 B2Synthetic Genomics, Inc. · 2010
- Assay methods using nicking endonucleases69US 8,715,933 B2NABsys, Inc. · 2014
- In vitro recombination method49US 9,534,251 B2Synthetic Genomics, Inc. · 2017
- CRISPR-CAS systems and methods for altering expression of gene products, structural information and inducible modular CAS enzymes21US 10,377,998 B2Massachusetts Institute of Technology · 2019
- CRISPR-Cas systems and methods for altering expression of gene products, structural information and inducible modular Cas enzymes11US 11,149,259 B2Massachusetts Institute of Technology · 2021